Skip to main content
EDIT logo

Editas Medicine, Inc.

EDITNASDAQHealthcareBiotechnology

$2.35Today:- (-)1Y −35.28%

As of Oct 16, 2026 close

Market cap
$291.08M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.66$4.33
Volume (live)
-
Avg. volume (3M)
3.00M

Editas Medicine, Inc. (EDIT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Editas Medicine, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy
Based on 11 unique analysts
(15 total ratings in last 90 days)
High Confidence6.0:1 Buy/Sell

Average Price Target

$5.67
+141.28% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest EDIT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Yanan Zhu
Wells Fargo
BuyUpgrades
$6.00
Debjit Chattopadhyay
Guggenheim
BuyUpgrades
$5.00
Edmund Ingham
Forbes
HoldInitiates Coverage
-
Ahan Chakraborty
Zacks Equity Research
HoldInitiates Coverage
-
Rick Bienkowski
Ladenburg Thalmann
BuyInitiates
$6.00
Alec Stranahan
BofA Securities
SellReiterates
-
Boris Peaker
JonesTrading
BuyMaintains
$8.00
Mitchell Kapoor
HC Wainwright
BuyReiterates
$3.00 → $5.00
Phil Nadeau
TD Cowen
BuyMaintains
-
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Luca Issi
RBC Capital
HoldMaintains
$4.00
Boris Peaker
JonesTrading
BuyMaintains
$8.00
Phil Nadeau
TD Cowen
BuyMaintains
-
Luca Issi
RBC Capital
HoldMaintains
$4.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 9, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for EDIT?

The analyst consensus rating for EDIT is Buy, based on the latest ratings from 11 analysts over the last 90 days.

What is the average price target for EDIT?

The average 12-month price target for EDIT is $5.67, representing an upside of 141.3% from the Oct 16, 2026 close of $2.35.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.